The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study

OBJECTIVE: To investigate the influence of comorbidities on treatment response, disease activity and persistence with first-line IL-17 inhibitor (IL-17i) treatment in patients with PsA. METHODS: Patients were divided into three groups depending on the presence and/or severity of comorbidities using...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Magnus B, Hansen, Rebekka L, Egeberg, Alexander, Jørgensen, Tanja S, Merola, Joseph Frank, Coates, Laura C, Kristensen, Lars Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118995/
https://www.ncbi.nlm.nih.gov/pubmed/37091296
http://dx.doi.org/10.1093/rap/rkad035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118995/
https://www.ncbi.nlm.nih.gov/pubmed/37091296
http://dx.doi.org/10.1093/rap/rkad035

Ejemplares similares